4.6 Letter

A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis

Elisa Teyssou et al.

Summary: Novel ANXA11 variants were associated with different clinical characteristics of ALS patients, with mutant ANXA11 accumulating in various brain regions and spinal cord but aggregation not seeming mandatory for neurodegeneration with potential involvement of additional partner proteins.

NEUROBIOLOGY OF AGING (2021)

Article Cell Biology

ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics

Minyeop Nahm et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Genetics & Heredity

ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia

Kang Zhang et al.

NEUROLOGY-GENETICS (2018)

Article Medical Laboratory Technology

Annexin A11 in disease

Jiasheng Wang et al.

CLINICA CHIMICA ACTA (2014)

Letter Clinical Neurology

A harmonized classification system for FTLD-TDP pathology

Ian R. A. Mackenzie et al.

ACTA NEUROPATHOLOGICA (2011)

Article Biochemistry & Molecular Biology

PrDOS: prediction of disordered protein regions from amino acid sequence

Takashi Ishida et al.

NUCLEIC ACIDS RESEARCH (2007)